SafeHeal
French tech company | Builders Republic
About
Clinical-stage medical-device company developing Colovac, an implant that protects the surgical join after colorectal surgery — placed endoluminally to shield the healing site from waste for the critical recovery window, then removed during a colonoscopy-like procedure, offering an alternative to a temporary stoma. Holds FDA Breakthrough Device status.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series C
- Founded
- 2015
- City
- PARIS
- Region
- IDF
- Legal name
- SAFEHEAL (SAFEHEAL)
- SIREN
- 812565166
- Tracked rounds
- 2
- Amount raised
- 75 M€ raised since 2020
Funding rounds
- Series C — 2025
- Series B — 2022
Investors
- Genesis Medtech
- Gideon Strategic Partners
- M&L Investments
- Sofinnova
- Solar Eclipse